Siga Technologies INC Warrants and Rights Outstanding
Siga Technologies INC (SIGA) had Warrants and Rights Outstanding of $0 as of 2022-12-31, per its 10-K filed 2023-03-02.
Discontinued › Balance Sheet › Equity, Attributable to Parent
us-gaap:WarrantsAndRightsOutstanding · last filed 2023-03-02
- 2022-12-31: Warrants and Rights Outstanding $0.00.
- 2022-09-30: Warrants and Rights Outstanding $0.00.
- 2022-06-30: Warrants and Rights Outstanding $0.00.
- 2022-03-31: Warrants and Rights Outstanding $6.17M.
| Period end | Warrants and Rights Outstanding |
|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-03-02 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-03 |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-04 |
| 2022-03-31 | $6.17M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $6.52M 10-K · filed 2023-03-02 |
| 2021-09-30 | $6.34M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $5.28M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $5.72M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $6.64M 10-K · filed 2022-03-03 |
| 2020-09-30 | $9.03M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $7.75M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $6.13M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $6.12M 10-K · filed 2021-03-04 |
| 2019-09-30 | $6.43M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $7.42M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $8.07M 10-Q · filed 2019-05-02 |
| 2018-12-31 | $12.38M 10-K · filed 2020-03-05 |
| 2018-09-30 | $10.73M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $14.41M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $14.77M 10-Q · filed 2018-05-04 |
| 2017-12-31 | $11.47M 10-Q · filed 2018-11-06 |
| 2017-09-30 | $7.36M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $7.06M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $7.35M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $6.73M 10-K · filed 2018-03-06 |
| 2016-09-30 | $6.95M 10-Q · filed 2016-11-02 |
| 2015-12-31 | $0.00 10-K · filed 2017-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |